RT Journal Article
SR Electronic
A1 Stejskal, David
A1 Bartek, Josef
A1 Pastorková, Radmila
A1 Růžička, Viktor
A1 Oral, Ivo
A1 Horalík, Dalimil
T1 OSTEOPROTEGERIN, RANK, RANKL
JF Biomedical papers
YR 2001
VO 145
IS 2
SP 61
OP 64
DO 10.5507/bp.2001.013
UL https://biomed.papers.upol.cz/artkey/bio-200102-0008.php
AB Osteoprotegerin, RANK (Receptor Activator of Nuclear factor kappa B) and RANKL (Receptor Activator ofNuclear faktor kappa B ligand) became the aim of intensive researche. RANK is considered as a hematopoieticsurface receptor controling osteoclastogenesis and calcium metabolism. RANKL may promote osteoresorption byinduction of cathepsin K gene expression. The present paper summarizes the most significant data in osteoprotegerin,RANK and RANKL problems obtained.